These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 6592156)
1. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells. Uchida A; Yagita M; Sugiyama H; Hoshino T; Moore M Int J Cancer; 1984 Sep; 34(3):375-81. PubMed ID: 6592156 [TBL] [Abstract][Full Text] [Related]
2. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D. Uchida A; Klein E Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288 [TBL] [Abstract][Full Text] [Related]
3. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039 [TBL] [Abstract][Full Text] [Related]
4. Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment. Ponzetta A; Benigni G; Antonangeli F; Sciumè G; Sanseviero E; Zingoni A; Ricciardi MR; Petrucci MT; Santoni A; Bernardini G Cancer Res; 2015 Nov; 75(22):4766-77. PubMed ID: 26438594 [TBL] [Abstract][Full Text] [Related]
5. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Märten A; Renoth S; von Lilienfeld-Toal M; Buttgereit P; Schakowski F; Glasmacher A; Sauerbruch T; Schmidt-Wolf IG Haematologica; 2001 Oct; 86(10):1029-37. PubMed ID: 11602408 [TBL] [Abstract][Full Text] [Related]
6. Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells. Punjabi CJ; Moore MA; Ralph P Cell Immunol; 1983 Apr; 77(1):13-22. PubMed ID: 6839366 [TBL] [Abstract][Full Text] [Related]
7. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
8. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579 [TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells. Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cells in the blood and bone marrow of the rhesus monkey. Gengozian N; Longley RE; Filler J; Good RA Cell Immunol; 1986 Aug; 101(1):24-38. PubMed ID: 3742605 [TBL] [Abstract][Full Text] [Related]
13. Lack of spontaneous and inducible natural killer cell activity in human bone marrow: presence of adherent suppressor cells. Uchida A Nat Immun Cell Growth Regul; 1983-1984; 3(4):181-92. PubMed ID: 6241292 [TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174 [TBL] [Abstract][Full Text] [Related]
16. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. Abo T; Cooper MD; Balch CM J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948 [TBL] [Abstract][Full Text] [Related]
17. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide. Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096 [TBL] [Abstract][Full Text] [Related]
18. The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma. Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N Anticancer Res; 1994; 14(2B):725-30. PubMed ID: 7516640 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Sharma B; Vaziri ND Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041 [TBL] [Abstract][Full Text] [Related]
20. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. Uchida A; Vánky F; Klein E J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]